Today: 21 May 2026
Microsoft stock drops in premarket after record AI spend puts Azure payoff in focus

Microsoft stock drops in premarket after record AI spend puts Azure payoff in focus

NEW YORK, Jan 29, 2026, 04:47 (ET) — Premarket

  • Microsoft shares slipped roughly 5.7% in premarket trading following the company’s quarterly results released late Wednesday
  • Investors focused sharply on a record capital spending bill aimed at AI infrastructure, alongside a cloud growth forecast that offered scant margin for missteps
  • Traders are keeping an eye on whether Big Tech can boost AI spending without hurting profit margins

Microsoft shares slipped 5.7% to roughly $454 in premarket Thursday, rattled by concerns over the rising expenses tied to its AI strategy following the latest quarterly report. The stock had closed Wednesday slightly higher, up 0.2% at $481.63.

This shift is significant because investors have long seen Microsoft as a key indicator of enterprise AI demand. More are now setting stricter conditions: spending is acceptable, but only if growth stays on track.

Big Tech earnings this week reflect that tension, as investors question if rising AI spending can translate into higher revenue and profits. “Microsoft’s deep ties to OpenAI … introduce concentration risk,” warned Zavier Wong, a market analyst at eToro. Reuters

Microsoft reported a 17% jump in revenue to $81.3 billion for the quarter ending Dec. 31. Operating income climbed 21% to $38.3 billion. GAAP net income stood at $38.5 billion, with adjusted profit coming in at $30.9 billion. Adjusted diluted earnings per share were $4.14, the company disclosed.

Cloud continued to drive growth. Microsoft Cloud revenue hit $51.5 billion, up 26%, with “Azure and other cloud services” climbing 39%, the company reported. It also returned $12.7 billion to shareholders via dividends and buybacks this quarter. Microsoft

Investors zeroed in on the bill fueling that expansion. Capital spending surged to $37.5 billion, soaring nearly 66% from last year, largely thanks to chips and data centers, Reuters reported. Microsoft also projected Azure growth between 37% and 38% for this quarter and signaled a slight slowdown in capital spending. Meanwhile, rising memory-chip costs are expected to pressure cloud margins over time.

Microsoft’s connection to OpenAI has returned to focus. The tech giant holds a 27% share in OpenAI and has lost its status as the startup’s exclusive cloud provider. Still, Microsoft keeps commercialization rights through 2032, according to the Associated Press.

During the post-earnings call, CEO Satya Nadella revealed that Microsoft’s M365 Copilot, the $30-a-month AI assistant for businesses, now boasts 15 million annual users. However, an investor concern highlighted by Eric Clark, portfolio manager of the LOGO ETF, is that costs are rising faster than sales. “Revenues are up 17% and the cost of revenues are up 19%,” he noted, per Reuters. Reuters

However, risks remain. Should AI demand cool off, or if capacity constraints and chip prices squeeze margins for longer than anticipated, the spending Microsoft uses to defend its edge could weigh on profits and free cash flow. That’s especially true as competitors roll out their own models and agents within enterprise software.

Traders will be looking to see if dip buyers return to MSFT during Thursday’s U.S. regular session and whether management offers clearer guidance on spending and margin trade-offs as analysts process the earnings. The next major trigger for the broader “AI spending” theme hits later Thursday, when Apple is set to release results after the close. Nasdaq

Stock Market Today

  • Lumentum Stock Analysis: Buy or Hold Amid Rising Demand and AI Growth
    May 20, 2026, 10:40 PM EDT. Lumentum is experiencing soaring demand as it supplies critical technology used by industry giants Nvidia and Intel. Despite this growth, The Motley Fool's Stock Advisor did not include Lumentum in its latest top 10 stock picks. Stock Advisor's selections have historically outperformed the market, with average returns of 990% versus 206% for the S&P 500, highlighting the significance of their recommendations. Investors should weigh Lumentum's current prospects against these insights before making decisions. The company remains a key player in AI-driven tech, but cautious evaluation is advised amid competitive recommendations.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus
Previous Story

Babcock share price today: BAB slips after fresh buyback filing, March year-end in focus

Australia stock market today: ASX 200 slips as rare earths tumble, RBA rate call looms
Next Story

Australia stock market today: ASX 200 slips as rare earths tumble, RBA rate call looms

Go toTop